Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
30 participants
OBSERVATIONAL
2024-11-15
2028-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
NCT02560467
Assessment of Wall Thickness in Hypertrophic Cardiomyopathy
NCT02234336
Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging
NCT03150342
Study of Myocardial Deformation Parameters in Patients With Hypertrophic Cardiomyopathy
NCT04112511
Study of Hypertrophic Cardiomyopathy Under Stress Conditions. Concordance Between Two Complementary Tests: Stress MRI and Exercice Stress Echocardiography
NCT02500420
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with HCM initiated on cardiac myosin inhibitor therapy
Patients with HCM who are being initiated on cardiac myosin inhibitor therapy for clinically indicated reasons.
myocardial contrast echo
Vasodilator stress myocardial contrast echocardiography will be performed at baseline and within 4 months of reaching target dose of a cardiac myosin inhibitor.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
myocardial contrast echo
Vasodilator stress myocardial contrast echocardiography will be performed at baseline and within 4 months of reaching target dose of a cardiac myosin inhibitor.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject being initiated on clinically-indicated cardiac myosin inhibitor therapy
Exclusion Criteria
* Lactation
* Allergy to ultrasound enhancing agent (lipid-stabilized) or regadenoson
* Serious AE to regadenoson
* Hypotension
* Serious bradycardia not addressed by pacemaker
* Moderate or greater reactive airways disease
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Virginia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jonathan Lindner, MD
Professor of Medicine
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
301910
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.